Unknown

Dataset Information

0

Effects of glucagon-like peptide-1 receptor agonists on kidney function and safety in type 2 diabetes patients.

ABSTRACT: Glucagon-like peptide-1 receptor agonists have been recommended in diabetic kidney disease patients.

SUBMITTER: Kim MK 

PROVIDER: S-EPMC8169368 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes.
| S-EPMC5556578 | biostudies-literature
Unknown Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists.
| S-EPMC4923410 | biostudies-literature
Unknown Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes.
| S-EPMC8017582 | biostudies-literature
Unknown Review of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes mellitus in patients with chronic kidney disease and their renal effects.
| S-EPMC6900024 | biostudies-literature
Unknown The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Renal Outcomes in Type 2 Diabetes.
| S-EPMC7136364 | biostudies-literature
Unknown Long-term management of type 2 diabetes with glucagon-like peptide-1 receptor agonists.
| S-EPMC5357070 | biostudies-other
Unknown Effects of glucagon-like peptide 1 receptor agonists on comorbidities in older patients with diabetes mellitus.
| S-EPMC6628533 | biostudies-literature
Unknown Cardiovascular effects of glucagon-like peptide 1 (GLP-1) receptor agonists.
| S-EPMC4216654 | biostudies-literature
Unknown Efficacy and tolerability of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus.
| S-EPMC4321868 | biostudies-literature
Unknown Indirect comparison of glucagon like peptide-1 receptor agonists regarding cardiovascular safety and mortality in patients with type 2 diabetes mellitus: network meta-analysis.
| S-EPMC7310317 | biostudies-literature